Diana Ernst, RPh

Most Recent Articles by Diana Ernst, RPh

Voluntary Recall of Diabetes Drug Due to Possible Microbial Contamination

Voluntary Recall of Diabetes Drug Due to Possible Microbial Contamination

By

The Food and Drug Administration has posted a recall notification for 2 lots of Riomet 500mg/5mL due to the possibility that the liquid may be contaminated with Scopulariopsis brevicaulis.

FDA: Vitamin B7 May Interfere With Lab Tests for Hormone Levels

FDA: Vitamin B7 May Interfere With Lab Tests for Hormone Levels

By

One patient taking high levels of biotin has died following falsely low troponin test results when a troponin test known to have biotin interference was used.

Increasing Body Surface Area Affected by Psoriasis May Increase T2D Risk

Increasing Body Surface Area Affected by Psoriasis May Increase T2D Risk

By

For patients with psoriasis, an increase in body surface area affected by the disease may be associated with a greater risk of type 2 diabetes.

FDA Approves Exenatide Extended-Release Injection for T2D

FDA Approves Exenatide Extended-Release Injection for T2D

By

The new formulation of Bydureon BCise allows for once-weekly administration with an autoinjector pen.

Drug Label Updated to Include Time Action Profile for Rapid-Acting Inhaled Insulin

Drug Label Updated to Include Time Action Profile for Rapid-Acting Inhaled Insulin

By

The prescribing information for Afrezza has been updated to include new clinical data relating to treatment effect and dosing.

More Articles by Diana Ernst, RPh

Sign Up for Free e-Newsletters

CME Focus